<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>Insight数据库 | wechat-feeds</title><link>http://MzA4MzkzMDYyNw.favicon.privacyhide.com/favicon.ico</link><description>丁香园 Insight 数据库（db.dxy.cn），拥有申报、临床、上市、药企等 10 大核心数据。致力于分享医药行业政策解读、药企大事和药品申报情报等</description><managingEditor> (hellodword)</managingEditor><pubDate>Thu, 15 Apr 2021 15:24:08 +0800</pubDate><image><url>http://MzA4MzkzMDYyNw.favicon.privacyhide.com/favicon.ico</url><title>Insight数据库 | wechat-feeds</title><link>http://MzA4MzkzMDYyNw.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>重磅！第五批集采开始报量，共 207 个品规，半数为注射剂（附最新过评清单）</title><link>https://mp.weixin.qq.com/s/Wa4IvR1LRvVzJsB0LADVBg</link><description></description><content:encoded><![CDATA[重磅！第五批集采开始报量，共 207 个品规，半数为注射剂（附最新过评清单）]]></content:encoded><pubDate>Thu, 15 Apr 2021 13:41:57 +0800</pubDate></item><item><title>刚刚！扬子江涉嫌垄断被罚 7.64 亿元</title><link>https://mp.weixin.qq.com/s/4RYxzZJz-sxF6iv5aqMM0g</link><description></description><content:encoded><![CDATA[刚刚！扬子江涉嫌垄断被罚 7.64 亿元]]></content:encoded><pubDate>Thu, 15 Apr 2021 13:41:57 +0800</pubDate></item><item><title>2021 Q1 生物制药企业并购交易 Top5</title><link>https://mp.weixin.qq.com/s/JxFPX5-6lH9USpg4iuR90w</link><description></description><content:encoded><![CDATA[2021 Q1 生物制药企业并购交易 Top5]]></content:encoded><pubDate>Wed, 14 Apr 2021 18:38:23 +0800</pubDate></item><item><title>NSCLC 术后辅助疗法，奥希替尼新适应症正式获批</title><link>https://mp.weixin.qq.com/s/KTSsUuSAk8iLphE8fHnFzQ</link><description></description><content:encoded><![CDATA[NSCLC 术后辅助疗法，奥希替尼新适应症正式获批]]></content:encoded><pubDate>Wed, 14 Apr 2021 18:38:23 +0800</pubDate></item><item><title>恒瑞 2 款单抗启动 III 期临床，分别靶向 PCSK9 和 IL17A</title><link>https://mp.weixin.qq.com/s/QvoZBRib-M2AceLiXH3ZiQ</link><description></description><content:encoded><![CDATA[恒瑞 2 款单抗启动 III 期临床，分别靶向 PCSK9 和 IL17A]]></content:encoded><pubDate>Wed, 14 Apr 2021 18:38:23 +0800</pubDate></item><item><title>吉利德 Trop-2 ADC 尿路上皮癌适应症获 FDA 加速批准</title><link>https://mp.weixin.qq.com/s/34wEpOY5SYvk3txpKbfZfw</link><description></description><content:encoded><![CDATA[吉利德 Trop-2 ADC 尿路上皮癌适应症获 FDA 加速批准]]></content:encoded><pubDate>Wed, 14 Apr 2021 18:38:23 +0800</pubDate></item><item><title>商业贿赂数额较大！某药企重磅药品被暂停挂网，多家药企降价修复信用</title><link>https://mp.weixin.qq.com/s/GT7Mkjuna_SV73GJATDo-Q</link><description></description><content:encoded><![CDATA[商业贿赂数额较大！某药企重磅药品被暂停挂网，多家药企降价修复信用]]></content:encoded><pubDate>Wed, 14 Apr 2021 18:38:23 +0800</pubDate></item><item><title>科伦药业罗红霉素片首家通过一致性评价</title><link>https://mp.weixin.qq.com/s/QpPuBDKqmy7iKwqmqnlfYw</link><description></description><content:encoded><![CDATA[科伦药业罗红霉素片首家通过一致性评价]]></content:encoded><pubDate>Wed, 14 Apr 2021 18:38:23 +0800</pubDate></item><item><title>顶级专家解读国家大政策，探索医药行业发展新蓝图</title><link>https://mp.weixin.qq.com/s/Diptvklm35ILW9intM1lQw</link><description></description><content:encoded><![CDATA[顶级专家解读国家大政策，探索医药行业发展新蓝图]]></content:encoded><pubDate>Wed, 14 Apr 2021 18:38:23 +0800</pubDate></item><item><title>这 103 个新药，获批临床了</title><link>https://mp.weixin.qq.com/s/m_yTtpH6gDmpJmHCr_eFOg</link><description></description><content:encoded><![CDATA[这 103 个新药，获批临床了]]></content:encoded><pubDate>Tue, 13 Apr 2021 19:04:18 +0800</pubDate></item><item><title>荣昌生物「泰他西普」正式开卖！挂网价 5172 元/盒</title><link>https://mp.weixin.qq.com/s/pHY3TmqWvlGrvwTkm7vc8w</link><description></description><content:encoded><![CDATA[荣昌生物「泰他西普」正式开卖！挂网价 5172 元/盒]]></content:encoded><pubDate>Tue, 13 Apr 2021 19:04:18 +0800</pubDate></item><item><title>已累计投入13 亿，康弘药业停止康柏西普国际 III 期临床</title><link>https://mp.weixin.qq.com/s/e7aJiW15DgAA1tHkLaXIrw</link><description></description><content:encoded><![CDATA[已累计投入13 亿，康弘药业停止康柏西普国际 III 期临床]]></content:encoded><pubDate>Tue, 13 Apr 2021 19:04:18 +0800</pubDate></item><item><title>6 个流标！新华-崇明区域医联体药品集采拟中选结果公布</title><link>https://mp.weixin.qq.com/s/pKG1Cf8OVip4y4f_Ar__eA</link><description></description><content:encoded><![CDATA[6 个流标！新华-崇明区域医联体药品集采拟中选结果公布]]></content:encoded><pubDate>Tue, 13 Apr 2021 19:04:18 +0800</pubDate></item><item><title>康希诺的 13 价肺炎球菌多糖结合疫苗启动 Ⅲ 期临床</title><link>https://mp.weixin.qq.com/s/S_w5n3AQg2_yApA8VKnjRg</link><description></description><content:encoded><![CDATA[康希诺的 13 价肺炎球菌多糖结合疫苗启动 Ⅲ 期临床]]></content:encoded><pubDate>Tue, 13 Apr 2021 19:04:18 +0800</pubDate></item><item><title>复宏汉霖 LAG-3 单抗获批临床</title><link>https://mp.weixin.qq.com/s/G484VXtFaLQ1CP27TcFjqg</link><description></description><content:encoded><![CDATA[复宏汉霖 LAG-3 单抗获批临床]]></content:encoded><pubDate>Tue, 13 Apr 2021 19:04:18 +0800</pubDate></item><item><title>百济、信达、康宁杰瑞....多家国内药企携新药数据亮相 2021 AACR</title><link>https://mp.weixin.qq.com/s/qY8TTWIS2e3pRoD_EAlpUA</link><description></description><content:encoded><![CDATA[百济、信达、康宁杰瑞....多家国内药企携新药数据亮相 2021 AACR]]></content:encoded><pubDate>Mon, 12 Apr 2021 18:44:21 +0800</pubDate></item><item><title>财政部发文！77 家药企查账结果来了，19 家被处罚</title><link>https://mp.weixin.qq.com/s/-kVpADKIXIez97MMQurQNQ</link><description></description><content:encoded><![CDATA[财政部发文！77 家药企查账结果来了，19 家被处罚]]></content:encoded><pubDate>Mon, 12 Apr 2021 18:44:21 +0800</pubDate></item><item><title>君实 PD-1 尿路上皮癌适应症正式获批，AZ 拥有全国独家推广权</title><link>https://mp.weixin.qq.com/s/UawKHJTciWlX_-SiVkP61Q</link><description></description><content:encoded><![CDATA[君实 PD-1 尿路上皮癌适应症正式获批，AZ 拥有全国独家推广权]]></content:encoded><pubDate>Mon, 12 Apr 2021 18:44:21 +0800</pubDate></item><item><title>半年一针长效降压！RNAi 新药积极临床结果发布</title><link>https://mp.weixin.qq.com/s/BoFi1AygbdRerRTH6Xtr_A</link><description></description><content:encoded><![CDATA[半年一针长效降压！RNAi 新药积极临床结果发布]]></content:encoded><pubDate>Mon, 12 Apr 2021 18:44:21 +0800</pubDate></item><item><title>复宏汉霖阿达木单抗新适应症获批</title><link>https://mp.weixin.qq.com/s/SVTv_w32eDbTkg9cWDvqAA</link><description></description><content:encoded><![CDATA[复宏汉霖阿达木单抗新适应症获批]]></content:encoded><pubDate>Mon, 12 Apr 2021 18:44:21 +0800</pubDate></item></channel></rss>